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Abstract
Background: Depression and anxiety disorders during adolescence can have detrimental consequences.
Both disorders are related to negative outcome in various areas during adolescence and are also predictive
of depression and anxiety disorders later in life. Especially parental psychopathology and being female are risk
factors that increase the probability of developing one of these disorders during adolescence. Research has
shown that prevention programs have promising results, especially for adolescents who have these risk factors.
Therefore, in this study, we will focus on the effectiveness of a prevention program ‘A jump forward’ that has
been developed for adolescent girls with a familial risk of depression and/or anxiety.
Methods/Design: We designed a randomized controlled trial to test the effectiveness of an indicated and
selective prevention program aimed at depression and anxiety in adolescent girls. Adolescents aged between
11 and 15 years old with depressive and/or anxiety symptoms and with parents who show indicators of parental
psychopathology will be randomly assigned to the experimental (N = 80) or control groups (N = 80). Participants
in the experimental group will follow a preventive intervention, consisting of six sessions of 90 minutes each. All
participants will complete baseline, intervention phase 1 (after session 2), intervention phase 2 (after session 4),
post-intervention, 6 month follow-up, and 12 month follow-up assessments. Furthermore, parents will be asked
to complete assessments at baseline, post-intervention, and 12-month follow-up. Primary outcome will be depressive
symptoms. Secondary outcomes will be anxiety symptoms, suicidal ideation, response style, negative cognitive errors,
parental emotional support and parental control, parental psychopathology, parenting stress and adolescents’
depression and anxiety symptoms according to the parents.
Discussion: This paper described the study designed to evaluate a program for preventing depression and/or
anxiety in high-risk adolescents over a 12-month follow-up period. If the program showed to be effective in reducing
symptoms of depression and anxiety and preventing adolescents from developing clinical levels of these disorders, our
results would be relevant to practice. Thus, the intervention could be used on a large scale. Moreover, this study aims
to contribute to the evidence-based prevention of depression and anxiety of adolescents.
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Background
Depression and anxiety disorders are a major public
health concern. The prevalence of clinical depression in
adolescents is approximately 5.6% [1]. Regarding anxiety
disorders, prevalence rates in children and adolescents
vary from 3% to 20% [2]. In addition, lifetime prevalence
of depression in adolescents is suggested to be 28.8% and
of anxiety disorders, lifetime prevalence is estimated at
16.6% [3]. These numbers do not even include children
and adolescents with increased levels of depressive and
anxiety symptoms, which are just below the diagnostic
threshold [3].
Depression and anxiety disorders during adolescence can
have detrimental consequences. That is, both disorders at
this age are related to negative outcomes in various areas,
such as poor psychosocial functioning [4], impairment in
social relations [5], poor academic performance [4,5], and
an increased risk for substance abuse [4]. Furthermore,
adolescent depression and anxiety are both associated
with depression, anxiety disorders, and even suicide
later in life [6,7]. Not only clinical levels of depression
or anxiety have negative outcomes, also subclinical levels
of depression or anxiety are associated with significant
distress and dysfunction, and they are also a risk for
future disorders [7-9].
It is important to examine the role of risk factors to
understand the onset and maintenance of psychopath-
ology during adolescence. With respect to depression and
anxiety disorders, several factors increase the probability
of developing one of these disorders. The first important
risk factor is parental psychopathology, as children of
parents with a depression are three times more likely
to develop an episode of a major depressive disorder
compared to children whose parents do not have this
disorder [4,10,11]. With regard to anxiety, 68% of children
of parents with this disorder show symptoms of an actual
anxiety disorder [12]. Furthermore, these children are
two to seven times more likely to develop an anxiety
disorder compared to children of parents without an
anxiety disorder [13-17]. Moreover, children of parents
with an anxiety disorder, a depression, or both, have
significantly higher odds of developing depression or
anxiety compared to children of parents without these
disorders [16]. The first explanation is that these children
experience more stress at home and that their parents
have less parenting skills. Nevertheless, the relations
between particular patterns of depression and anxiety
symptoms in adolescents on the one hand and parental
psychopathology, parenting characteristics, parental
emotional support, and parental control on the other
hand remain to be further specified. The second
explanation is that a genetic predisposition increases
the probability of developing mood and anxiety disorders.
Theorists assume that depression and anxiety disorders
are familial disorders and partly the result of a genetic
heredity. However, the largest part of evidence suggests
that depressive and anxiety symptoms rather than specific
disorders are heritable. This genetic influence accounts
for 30-50% of the variance in these symptoms [18-23].
The second risk factor in the development of depression
and anxiety during adolescence is gender. Females have
been identified as being at a higher risk of developing
depression and anxiety disorders [24-26]. Differences
between boys and girls seem to arise during puberty,
and particularly adolescent girls are vulnerable to develop
a clinical depression [27] and often show subclinical
depressive and anxiety symptoms [28].
Given the high prevalence rates of depression and
anxiety disorders in children and adolescents as well as
the effect these disorders have on their current and future
psychosocial functioning, many treatment programs have
been developed. Most of these programs are based on
cognitive behavioral therapy (CBT), which addresses, for
example, dysfunctional emotions, maladaptive behaviors,
and cognitive processes. That is, these negative cognitions
generally result in higher levels of depression and anxiety.
This implies that response style and cognitive errors
are assumed to mediate the relation between prevention
programs and symptoms of depression and anxiety.
CBT is known to be effective in treating and preventing
depression and anxiety in adolescents [29-31] individually
as well as in groups [32,33]. Importantly, it has been shown
that the coping skills learned from a CBT intervention
could mediate the relation between family stressors and
the actual development of adolescent depression or anxiety
disorders [34].
Adolescents with symptoms of depression and/or anx-
iety who have parents with elevated levels of depression
and/or anxiety have a relative high risk to develop
depression or anxiety disorders later in life. Because
children of parents with a mental illness often develop
maladaptive self-schemas as a consequence of negative
family-related events, CBT would be a preferred in-
tervention [34]. Despite these facts, to date, only a
limited number of studies have been conducted to
examine the prevention of depression and/or anxiety
disorders in adolescent offspring of depressed or anxious
parents by means of CBT [35-38]. The findings showed
that preventive interventions had positive outcomes, such
as decreased symptomatology. However, none of these
preventive interventions targeted both depression and
anxiety, although these disorders have a high comorbidity,
simultaneous development [39,40], and a considerable
overlap in symptoms, especially during adolescence
[41]. Since the aetiology and pathogenesis of depression
and anxiety also overlap substantially, we argue that the
prevention programs should focus on both disorders
simultaneously, specifically during adolescence. Therefore,
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common factors can be prevented, and there might be
greater potential to obtain benefits [42,43].
The current study combines indicated prevention and
selective prevention [44], which respectively refer to
the prevention provided to adolescents with elevated
levels of depression or anxiety and to the prevention
provided to targeted subgroups distinguished by specific
traits, in our case children who have parents with elevated
levels of depression or anxiety. As mentioned above,
these adolescents have an extra high risk to develop a
depression or anxiety disorder. The adolescents allocated
to the experimental group will undergo a preventive
intervention that consists of six weekly meetings of
90 minutes each. It will focus on acquiring knowledge
of depression and anxiety, learning to recognize and
distinguish emotions, dealing with difficult situations,
solving social problems, and creating and using a sup-
portive social network. Throughout the program, the
adolescents will complete various exercises based on
cognitive behavioral therapy, behavioral activation, and
exposure.
The primary aim of this study is to test the effective-
ness of the program ‘Een Sprong Vooruit’ [A Jump
Forward] in preventing depressive and anxiety symptoms
among adolescents with elevated symptoms of depression
and anxiety who have parents with elevated symptoms
of depression and/or anxiety. The secondary aim is to
determine whether response style and cognitive errors
mediate and whether parental psychopathology, parenting
stress, parental emotional support and parental control
moderate the effectiveness of the prevention program.
Methods
The study design will be reported in accordance with the
CONSORT 2010 statement for reporting parallel group
randomized trials [45]. The medical ethics committee
CMO Region Arnhem-Nijmegen, The Netherlands, has
approved this study.
Design
The present study is designed as a non-blinded ran-
domized controlled trial (RCT) with two conditions
(intervention versus control). Adolescents will be screened
for depression, anxiety, suicide ideation, and parental
psychopathology in order to select high-risk adolescents.
The program is designed for indicated and selective
prevention [44]; therefore, adolescents with elevated
symptoms of depression and/or anxiety as well as with
a parent who has elevated levels of depression or
anxiety symptoms will be selected and recruited.
After the completion of screening and recruitment,
participants will be randomized to either intervention or
control group. The assessments will be conducted at
baseline (T0), during the intervention phase after session
2 (T1), during the intervention phase after session 4 (T2),
at post-intervention (T3), at 6-month months follow-up
(T4), and at 12-month follow-up (T5). The overall study
design is captured in Figure 1.
Participants’ eligibility
Adolescents with depressive and/or anxiety symptoms
who are willing to participate in a prevention program
will be eligible for this study. Inclusion criteria are age
between 11-15 years old; increased levels of depression
and/or anxiety; at least one of the parents showing
symptoms of a depression or anxiety disorder; and both
adolescent and parents having sufficient knowledge of
the Dutch language. Exclusion criteria are the absence
of parental permission; adolescent already receiving
treatment for mental health problems; and presence of
prominent suicidal ideation (score 2 on CDI item: a
desire to kill oneself, if given the chance).
Recruitment
Students in their first and second year of secondary
school, from vocational training up to pre-university
level, will receive written information about the screening
and the study. After receiving passive consent, these
students will be screened for depression, anxiety, and












































Figure 1 Overall study design.
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sion criteria will be randomly assigned to one of the two
conditions. After that, the adolescents and their parents
will receive verbal and written information about the
study and written informed consent from adolescents
and parents will be obtained.
Sample size
The sample size is based on the expected difference
(Cohen’s d = 0.50) on the primary outcome variable
between the experimental and control group at 12 months
follow-up (based on a meta-analytic review [46]). With
an alpha of 0.05 and a power of 0.80 of a two-tailed
test, 64 participants will need to be included in each
condition. The data will be analyzed according to the
intent-to-treat principle. Multiple imputations will be
used for missing observations at follow-ups. We intend
to increase the sample size by 25% to compensate for
dropout and potential loss of power due to clustering
of data, resulting in 160 participants (80 in experimental
condition and 80 in control condition).
The program
‘Een Sprong Vooruit’ [A Jump Forward], which consists
of 6 sessions, each 90 minutes long. In the first session,
the participants will learn about emotions, anxiety, and
depression and their experiences with their parent’s
mental health problem. The adolescents learn about
emotions they experience, and they will learn to
recognize them. During this program, they will use a
schedule to examine the relations among activating
events, beliefs, emotional consequences and behavioral
consequences. In the second session, the adolescents
will learn about the relationship between activating
events, beliefs, and emotional consequences. Beliefs can
be optimistic or pessimistic and play a major role in the
emotional consequences. The adolescents in the study will
learn to recognize pessimistic beliefs. In the third session,
adolescents will be taught several strategies to replace
the pessimistic beliefs with optimistic beliefs. They will
learn to recognize the (negative) pattern of their beliefs,
replace them, and prove that the alternative belief is
true. In the fourth session, adolescents will learn that in
some situations, the beliefs cannot be replaced or changed
and that they have to change their behavior to influence
the emotional consequences. Therefore, the assignments
will comprise both pleasant and less pleasant activities.
Furthermore, they will learn to organize and structure
large tasks. In the fifth session, the adolescents will learn
about anxiety and the development of fear over time.
By means of exposure, they will learn to divide fearful
activities into small steps, practice those steps, and
experience the decrease in anxiety. In the sixth and last
session, the fearful tasks will be evaluated and practiced
again. Furthermore, the adolescents will learn that social
support sometimes makes things easier. They will practice
asking people in their social environment for help. Finally,
the adolescents will take a look at the future and talk
about how they can influence it.
Study outcome measures
For an elaborate overview of study outcome measures,
see Table 1.
Screening measures
To assess the eligibility to participate, students will be
screened for depressive and anxiety symptoms and sui-
cidal ideation using the Children’s Depression Inventory
2 (CDI 2) and Spence Children Anxiety Scale (SCAS).
Furthermore, students will be asked to complete some
questions about parental psychopathology.
Primary outcome measure
Depression in children and adolescents will be measured
with the CDI 2 [47]. The CDI 2 contains 28 items, each
consisting of three statements graded in severity from 0
to 2. This instrument has good internal consistency and
convergent validity [48].
Secondary outcome measures
Anxiety will be measured with the SCAS [49]. This 44-
item self-report questionnaire rates the frequency of
symptoms on a 4-point scale ranging from “never” to
“always”. The scale has demonstrated high internal
consistency, high concurrent validity, and adequate test-
retest reliability across both child [50] and adolescent
[51] samples.
Suicidal ideation will be measured with the suicide
item of the CDI 2 [47], with scores of 0 (“no suicidal
ideation”), 1 (“thoughts of wanting to kill oneself, with
Table 1 Overview of assessments
Screening T0 T1 T2 T3 T4 T5
Adolescent
Depression (CDI 2) X X X X X X X
Anxiety (SCAS) X X X X X X X
Suicidal ideation (CDI 2) X X X X X X X
Response style (CRSQ) X X X X X X
Cognitive errors (CNCEQ-R) X X X X X X
Relational support (RSI) X X X
Parent1
Parental psychopathology (BSI) X
Parenting stress (OBVL) X X X
Child depression (CDI 2 P) X X X
Child anxiety (SCAS-P) X X X
1Both parents will complete the questionnaires. Only parents who have
absolutely no contact with children will be excluded.
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no intent to do so”), and 2 (“a desire to kill oneself, if
given the chance”). Participants with a score of 2 will be
excluded from the study and referred to a therapist
within an institute of mental health care or a general
practitioner.
Response style will be measured with the Children’s Re-
sponse Style Questionnaire (CRSQ) [52]. This question-
naire consists of three subscales: ruminative response,
distracting response, and problem solving. Items are rated
on a 4-point scale ranging from “almost never” to “almost
always”. The scale has moderate levels of internal
consistency.
Negative cognitive errors will be measured with the
Children’s Negative Cognitive Errors Questionnaire –
Revised (CNCEQ-R) [53], which divides negative cognitive
errors into five error categories, namely ‘overgeneralizing’,
‘personalizing’, ‘selective abstraction’, ‘threat conclusion’,
and ‘underestimation of the ability to cope’. Items are
rated on a 5-point scale from “not at all like I would
think” to “almost exactly like I would think”. The ques-
tionnaire is a revised version of the CNCEQ, which has a
good internal consistency and test-retest reliability [54].
Parental emotional support and parental control will
be measured respectively with ‘Warmth versus Hostility’
and ‘Respect for Autonomy versus setting limits’, which
are two subscales of the Relational Support Inventory
(RSI) [55]. Both subscales have six items rated on a 5-
point scale ranging from “very untrue” to “very true”.
The reliability varies from low to moderate.
Parental psychopathology will be measured with the
Brief Symptom Inventory (BSI) [56]. The BSI is a short
version (53 items) of the Symptom Checklist-90 (SCL-90)
[57] divided into 9 symptom dimensions: Somatization,
Obsessive-compulsive symptoms, Interpersonal sensitivity,
Depression, Anxiety, Hostility, Phobic anxiety, Paranoid
ideation, and Psychoticism. Items are rated on a 5-point
scale from “not at all” to “extremely”. Both international
[58] and national studies [59] showed that the question-
naire has good psychometric properties.
Parenting stress will be measured with the Opvoeding
Belasting Vragenlijst (OBVL) [Parenting Stress Question-
naire] [60]. It is used to determine how parents experience
their child, how they interact with their child, and how
they feel about their own health. The questionnaire
consists of 34 items scored on a 4-point scale ranging
from “not true” to “very true”. This instrument has a
good reliability and satisfactory validity [60].
Depression of the child according to the parent will be
measured with the parent report of the CDI 2 [47]. Same
as the child report, this questionnaire consists of 28 items,
and for each item, there are three possible answers; 0
indicating the absence of symptoms, 1 indicating mild
symptoms, and 2 indicating definite symptoms. The
validity of this instrument is qualified as good [48].
Anxiety of the child according to the parent will be
measured using the Spence Children’s Anxiety Scale-Parent
Version (SCAS-P) [49]. The items of the SCAS-P were
formulated as closely as possible to the corresponding items
of the child version of the SCAS. The parent version of the
SCAS demonstrates sound psychometric properties [61].
Data analysis/statistical analysis
Data will be analyzed according to the intent-to-treat
principle and will also be analyzed separately for the
completers only. Multiple imputations will be used for
missing observations at follow-ups. Regression analyses
will be conducted to test differences in the development
of depressive and anxiety symptoms between children in
the intervention condition and children in the control
condition. The results of the study will be reported in
accordance with the CONSORT statement [45]. To inves-
tigate the mediating role of secondary outcome measures,
such as response style and cognitive errors, mediation
analyses will be performed in Mplus using bootstrap
methods.
Possible baseline differences between the two conditions
in demographic variables, depressive symptoms, and
anxiety symptoms will be checked. Moreover, variables
that show different distributions between the two
groups will be entered as confounders in all models
testing the effectiveness of the intervention.
Discussion
This study protocol presents the design of a randomized
controlled trial, which will evaluate the effect of a preven-
tion program for depression and anxiety for adolescents
with a high familial risk. The primary aim of the study
will be to evaluate the effectiveness of the prevention
program for depression and/or anxiety among 11-15 year
old female adolescents. Our secondary aim will be to
examine theoretically meaningful parent and child factors
that possibly moderate or mediate the effect of the preven-
tion program. It is hypothesized that adolescents in the
intervention condition will show lower levels of depressive
and anxious symptoms during the follow-up compared to
adolescents in the control group without a prevention
program. Furthermore, it is hypothesized that response
style and cognitive errors will mediate the effect of the
program and that parental psychopathology, parenting
stress, parental emotional support, and parental control
will moderate the effect of the prevention program.
Strengths and limitations
The strength of the study is that it will conduct follow-up
assessments at 12 months in addition to 6 months in
both the intervention group and the control group. This
will provide the opportunity to evaluate the long-term
effects of this prevention program. Additional strength
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of the study is that in contrast to the most RCT studies,
we will focus not only on the effectiveness of the
program, but also on the mediators of change (i.e.,
how the intervention works). Finally, the prevention
program will consist of only six sessions; therefore,
we expect a low dropout rate.
This study also has limitations. We will not include
a placebo intervention group, limiting the extent to
which decreased depression and anxiety symptoms in
the intervention group can be uniquely ascribed to the
prevention program. Another study limitation is its
selective design. It will enable a possible labeling or
stigmatization effect, which can occur during the process
of identification and participation of adolescents at risk
in the prevention program.
Implications for practice
Depression and anxiety are the most common internaliz-
ing disorders among adolescents. Prolonged and elevated
levels of depression and anxiety can develop into clinical
disorders. They can also cause significant distress and
dysfunction, even at subclinical levels [8]. Given the
prevalence of depression and anxiety and their high rates
of recurrence, there is a need for effective assessment,
treatment, and prevention. Schools can play an important
role in the identification of children and adolescents
with elevated depressive and anxiety symptoms. If the
prevention program shows to be effective in reducing
elevated levels of depression and anxiety and preventing
adolescents from developing a clinical mental health
disorder, our results will be relevant to practice. Hence,
the intervention will be able to be used on large scale.
Conclusion
This paper described the design of the study that will
evaluate a prevention program for depression and anxiety
in high-risk adolescents over a 12 months follow-up
period. The targeted adolescents are at risk because both
they and their parents have elevated levels of depression
or anxiety. This study aims to contribute to the evidence-
based prevention of depression and anxiety of adolescents.
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